FIELD: medicine.
SUBSTANCE: invention refers to laboratory diagnostics and can be used for evaluation of phagocytic activity of neutrophils in human peripheral blood. Phagocytosis objects are recombinant luminescent bacteria, namely microorganisms Escherichia coli with cloned luxCDABE genes Photobacterium leiognathii, pre-opsonised during 10 min with normal human immunoglobulin in end concentration 6-10 mg/ml. Luminole is additionally introduced to the sample to end concentration 10-3 M. Intensity of luminole-dependent phagocytic chemoluminescence and bioluminescence of bacterial targets are counted separately by evaluating luminescence in two various spectral bands: <430 nm for evaluation of chemoluminescence and >540 nm for evaluation of bioluminescence.
EFFECT: possibility for complex evaluation of activation level of oxygen-dependent bactericidal phagocytic systems, and improved test accuracy.
1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING PHAGOCYTIC ACTIVITY OF NEUTROPHILS BY MICROBIOLOGICAL APPROACH | 2019 |
|
RU2727880C1 |
| METHOD FOR DETERMINING PHAGOCYTIC ACTIVITY OF HUMAN PERIPHERAL BLOOD NEUTROPHILS FROM BIOLUMINESCENCE EXTINCTION DEGREE DATA | 2005 |
|
RU2292553C1 |
| METHOD FOR ASSESSING PHAGOCYTIC ACTIVITY OF NEUTROPHILS | 2023 |
|
RU2824345C1 |
| METHOD OF BIOCHEMILUMINESCENT ASSESSMENT OF RUMEN FLUID TOXICITY IN VITRO | 2013 |
|
RU2603104C2 |
| METHOD OF DETERMINATION OF NONSPECIFIC ANTIBACTERIAL ORGANISM RESISTANCE | 1992 |
|
RU2068997C1 |
| METHOD OF DETERMINING BIOLOGICAL (ANTIMICROBIAL) ACTIVITY OF DEFENSINS AND DERIVATIVES THEREOF | 2009 |
|
RU2405835C1 |
| METHOD OF NANOCARBON ANALYSIS FOR BIOTOXICITY | 2010 |
|
RU2437938C2 |
| METHOD TO DETERMINE BACTERICIDE PROPERTIES OF BLOOD SERUM | 2011 |
|
RU2489489C1 |
| METHOD FOR DETERMINING THE THERAPEUTIC APPROACH TO CHRONIC RECURRENT BACTERIAL PROSTATITIS | 2020 |
|
RU2723997C1 |
| METHOD TO DETERMINE NEUTROPHIL CAPACITY TO PRODUCE ACTIVATED OXYGEN METABOLITES IN EXPERIMENT | 1993 |
|
RU2089907C1 |
